CHGCF
Price
$39.99
Change
-$3.97 (-9.03%)
Updated
Aug 15 closing price
Capitalization
69.82B
DSKYF
Price
$24.30
Change
+$0.21 (+0.87%)
Updated
Aug 15 closing price
Capitalization
46.53B
Interact to see
Advertisement

CHGCF vs DSKYF

Header iconCHGCF vs DSKYF Comparison
Open Charts CHGCF vs DSKYFBanner chart's image
Chugai Pharmaceutical
Price$39.99
Change-$3.97 (-9.03%)
Volume$6.42K
Capitalization69.82B
Daiichi Sankyo
Price$24.30
Change+$0.21 (+0.87%)
Volume$7.66K
Capitalization46.53B
CHGCF vs DSKYF Comparison Chart in %
Loading...
CHGCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DSKYF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CHGCF vs. DSKYF commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CHGCF is a Hold and DSKYF is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 17, 2025
Stock price -- (CHGCF: $39.99 vs. DSKYF: $24.30)
Brand notoriety: CHGCF and DSKYF are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: CHGCF: 260% vs. DSKYF: 41%
Market capitalization -- CHGCF: $69.82B vs. DSKYF: $46.53B
CHGCF [@Pharmaceuticals: Major] is valued at $69.82B. DSKYF’s [@Pharmaceuticals: Major] market capitalization is $46.53B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $628.62B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $87.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CHGCF’s FA Score shows that 1 FA rating(s) are green whileDSKYF’s FA Score has 1 green FA rating(s).

  • CHGCF’s FA Score: 1 green, 4 red.
  • DSKYF’s FA Score: 1 green, 4 red.
According to our system of comparison, both CHGCF and DSKYF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CHGCF’s TA Score shows that 3 TA indicator(s) are bullish while DSKYF’s TA Score has 4 bullish TA indicator(s).

  • CHGCF’s TA Score: 3 bullish, 5 bearish.
  • DSKYF’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, DSKYF is a better buy in the short-term than CHGCF.

Price Growth

CHGCF (@Pharmaceuticals: Major) experienced а -9.03% price change this week, while DSKYF (@Pharmaceuticals: Major) price change was +3.54% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +2.35%. For the same industry, the average monthly price growth was +5.72%, and the average quarterly price growth was +12.95%.

Industries' Descriptions

@Pharmaceuticals: Major (+2.35% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CHGCF($69.8B) has a higher market cap than DSKYF($46.5B). CHGCF has higher P/E ratio than DSKYF: CHGCF (24.49) vs DSKYF (22.94). CHGCF YTD gains are higher at: -4.170 vs. DSKYF (-8.647). CHGCF has higher annual earnings (EBITDA): 556B vs. DSKYF (405B). CHGCF has more cash in the bank: 1.03T vs. DSKYF (848B). DSKYF has higher revenues than CHGCF: DSKYF (1.76T) vs CHGCF (1.2T).
CHGCFDSKYFCHGCF / DSKYF
Capitalization69.8B46.5B150%
EBITDA556B405B137%
Gain YTD-4.170-8.64748%
P/E Ratio24.4922.94107%
Revenue1.2T1.76T68%
Total Cash1.03T848B121%
Total DebtN/A102B-
FUNDAMENTALS RATINGS
CHGCF vs DSKYF: Fundamental Ratings
CHGCF
DSKYF
OUTLOOK RATING
1..100
765
VALUATION
overvalued / fair valued / undervalued
1..100
31
Undervalued
79
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
983
PRICE GROWTH RATING
1..100
6056
P/E GROWTH RATING
1..100
6895
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CHGCF's Valuation (31) in the null industry is somewhat better than the same rating for DSKYF (79). This means that CHGCF’s stock grew somewhat faster than DSKYF’s over the last 12 months.

CHGCF's Profit vs Risk Rating (100) in the null industry is in the same range as DSKYF (100). This means that CHGCF’s stock grew similarly to DSKYF’s over the last 12 months.

DSKYF's SMR Rating (3) in the null industry is significantly better than the same rating for CHGCF (98). This means that DSKYF’s stock grew significantly faster than CHGCF’s over the last 12 months.

DSKYF's Price Growth Rating (56) in the null industry is in the same range as CHGCF (60). This means that DSKYF’s stock grew similarly to CHGCF’s over the last 12 months.

CHGCF's P/E Growth Rating (68) in the null industry is in the same range as DSKYF (95). This means that CHGCF’s stock grew similarly to DSKYF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CHGCFDSKYF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
59%
Bullish Trend 3 days ago
79%
Momentum
ODDS (%)
Bearish Trend 3 days ago
64%
Bearish Trend 3 days ago
77%
MACD
ODDS (%)
Bearish Trend 3 days ago
47%
Bearish Trend 3 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
54%
Bullish Trend 3 days ago
71%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
38%
Bullish Trend 3 days ago
72%
Advances
ODDS (%)
Bullish Trend 5 days ago
55%
Bullish Trend 5 days ago
72%
Declines
ODDS (%)
Bearish Trend 3 days ago
74%
Bearish Trend 7 days ago
72%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
43%
Bearish Trend 3 days ago
88%
Aroon
ODDS (%)
Bearish Trend 3 days ago
34%
Bearish Trend 3 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
CHGCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DSKYF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SGMO0.580.04
+7.41%
Sangamo Therapeutics
NAGE10.020.31
+3.19%
Niagen Bioscience Inc
PRU105.92-0.90
-0.84%
Prudential Financial
HGV44.39-0.87
-1.92%
Hilton Grand Vacations
AEHL3.49-0.08
-2.24%
Antelope Enterprise Holdings Limited

CHGCF and

Correlation & Price change

A.I.dvisor tells us that CHGCF and CHGCY have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CHGCF and CHGCY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CHGCF
1D Price
Change %
CHGCF100%
-9.03%
CHGCY - CHGCF
32%
Poorly correlated
+2.36%
CMOPF - CHGCF
10%
Poorly correlated
N/A
DSKYF - CHGCF
-2%
Poorly correlated
+0.86%
CHJTF - CHGCF
-3%
Poorly correlated
N/A
DSNKY - CHGCF
-5%
Poorly correlated
+2.87%
More

DSKYF and

Correlation & Price change

A.I.dvisor indicates that over the last year, DSKYF has been loosely correlated with DSNKY. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if DSKYF jumps, then DSNKY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DSKYF
1D Price
Change %
DSKYF100%
+0.86%
DSNKY - DSKYF
43%
Loosely correlated
+2.87%
CHGCY - DSKYF
8%
Poorly correlated
+2.36%
CHJTF - DSKYF
8%
Poorly correlated
N/A
CSPCY - DSKYF
6%
Poorly correlated
+0.18%
GIFLF - DSKYF
6%
Poorly correlated
N/A
More